| Name: |
|
| Other Names: |
|
|
Classification:
|
|
|
Mechanism of Action:
|
- Increases the arterial pressure of oxygen therefore improving gas exchange and oxygen delivery to tissues provided that there are functional alveolar units.
|
|
Indications:
|
- Hypoxia
- Respiratory distress
- Carbon monoxide poisoning
- Acute coronary syndrome
- ROSC
- Stroke
- Major trauma
|
|
Contraindications:
|
|
|
Precautions:
|
- Caution with CO2 retainers
|
|
Adverse Effects:
|
- Light-headedness
- Respiratory failure in a small number of patients who are CO2 retainers
|
|
Dose:
|
|
| |
- SpO2 Ranges:
- Ischemic chest pain: 94-99%
- ROSC: 94-99%
- Sepsis: 100%
- Stroke: 92-99%
- Major trauma: 100%
- Respiratory distress: >92%
- Patient with COPD: 88-92%
|
| Supplied: |
- Oxygen tanks of 3 sizes:
- M = 3000 L volume (tank factor 1.56)
- E = 660 L volume (tank factor 0.28)
- D = 400 L volume (tank factor 0.16)
- Note: Calculation for time remaining in tank equals = ([Pressure on gauge – 200 psi] x tank factor)/Flow rate (lpm)
|
| Special Notes: |
- If patients are within their targeted oxygen saturation, it is not necessary to administer supplemental oxygen.
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
|
Modifié le: jeudi, 16 janvier 2025, 14:08